To date, the FDA has approved many other liposomal formulations such as DaunoXome®, which contains daunorubicin, and Marquibo®, which contains vincristine sulfate for cancer therapy [123] as well as other types of nanoparticle including polymeric micelles containing paclitaxel (Genexol® PM), micelles built with PEG and a poly(γ-benzyl L-glutamate, containing cisplatin [124] and albumin nanoparticles with paclitaxel (Abraxane®) [125]. The gene discussed is ALB; the disease is cancer.